Approved through 7/93 under the condition that no later than 6/93, AHCPR briefs OMB on its survey experience in the Prescription Drug module and its plans for further testing alternative methods for relating expenditures to institutional drug utilization. In particula OMB is interested in the availability, variety, and characteristics of institutional data bases for drug expenditures. In the briefing, AHCP should: 1) summarize its findings in regard to the quality, validity, and comprehensiveness of facility responses to the Recontact Log; 2) based on survey knowledge of existing data sources, facility and pro fessional behavior, etc., the drug expenditure data options most feasible for pretesting, e.g. reliance on pharmacy records, a mixture of pharmacy records and abstraction, medical record abstraction and imputation, etc.; and 3) an analysis of each alternative's relative cost versus the anticipated quality and timeliness of the drug expenditure data.
Inventory as of this Action
Requested
Previously Approved
07/31/1993
07/31/1993
1,008
0
0
997
0
0
0
0
0
THIS IS ROUND 2 OF A METHODOLOGY STUDY WHICH WILL ASSESS METHODS FOR ENHANCING THE QUALITY OF DATA ON MEDICAL CARE AND EXPENDITURES IN THE INSTITUTIONAL POPULATION COMPONENT AND FOR IMPROVING THE EFFICIENCY OF DATA COLLECTIONS.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.